Global challenges for clinical pharmacology in the developing world.
The increasing burden of HIV care threatens to overwhelm health-care providers and systems in the developing world. Clinical pharmacologists, applying the training that they possess in regulatory science, rational prescribing, and teaching therapeutics, could improve the delivery of care in that setting. However, the shortage of clinical pharmacologists and the emigration of health-care providers limit the ability to take advantage of this approach. Possible solutions are outlined in this Commentary.
Blaschke
T F
TF
Division of Clinical Pharmacology, Stanford University School of Medicine, Stanford, California, USA. blaschke@stanford.edu
D003906:Developing Countries; D004346:Drug Information Services / Q000458:organization & administration; D017723:Drug Utilization Review; D004496:Education, Continuing / Q000458:organization & administration; D014943:Global Health; D015658:HIV Infections / Q000517:prevention & control* / Q000628:therapy*; D006801:Humans; D010601:Pharmacology, Clinical / Q000193:education / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D010606:Pharmacy and Therapeutics Committee / Q000458:organization & administration; D024382:Professional Role; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration; D014944:World Health Organization